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Methicillin-resistant Staphylocoocus aureus (MRSA) 
harboring mecALGA251 has been isolated from humans and 
ruminants. Database screening identifi ed this MRSA variant 
in cats, dogs, and a guinea pig in Germany during 2008–
2011. The novel MRSA variant is not restricted to ruminants 
or humans, and contact with companion animals might pose 
a zoonotic risk.
Worldwide, methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infectious 
diseases in humans and animals (1). The staphylococcal 
cassette chromosome mec (SCCmec) harbors the mecA 
gene, which encodes an additional penicillin-binding 
protein 2a. In the presence of β-lactam antimicrobial drugs, 
this transpeptidase substitutes an essential cross-linking 
step in the process of cell-wall building (2). Eleven distinct 
SCCmec elements have been described (3). Recent reports 
of MRSA carrying a novel mecA homologue (mecALGA251) 
of a predicted amino acid identity of 62% with other 
mecA allotypes raised awareness about these pathogens, 
which possibly remain undetected by conventional PCR 
approaches (3–5). This lack of detection might have led to 
underestimation of the novel MRSA variant among clinical 
samples of human and animal origin.
High-level congruence between S. aureus of animal 
and human lineages has been demonstrated (6), and nearly 
every sequence type (ST) reported for MRSA associated 
with infections in companion animals was also commonly 
found in humans (1). Because previous reports indicated 
that MRSA harboring mecALGA251 originated from either 
human or ruminant hosts (3–5), we searched our database 
for companion animal isolates that displayed a MRSA 
phenotype but had failed to give a positive PCR result for 
mecA.
The Study
From November 2008 through December 2011, MRSA 
of companion animal origin was routinely isolated from 
specimens submitted for diagnostic purposes to Vet Med 
Labor GmbH in Ludwigsburg, Germany, or to the Institute 
of Microbiology and Epizootics, Freie Universität Berlin, 
in Berlin, Germany. S. aureus was confi rmed as described 
(7) and stored in glycerol stocks at −80°C.
PCR routinely used to confi rm methicillin resistance 
and species identity had failed to produce a positive signal 
for mecA in 10 MRSA isolates from companion animals 
(2 isolates from dogs, 7 from cats, and 1 from a guinea 
pig) (8). We screened these 10 isolates for the mecA 
homologue by using the PCR method published by Cuny et 
al. (5) and sent the amplicons obtained to LGC Genomics 
GmbH (Berlin, Germany) for sequencing. Automated 
antimicrobial drug susceptibility testing was performed 
by using the bioMérieux VITEK 2 system (Nürtingen, 
Germany) according to the manufacturer’s instructions. 
The following drugs were tested according to Clinical 
and Laboratory Standards Institute guidelines M31–A3: 
penicillin, ampicillin–sulbactam, oxacillin, gentamicin, 
kanamycin, enrofl oxacin, marbofl oxacin, erythromycin, 
clindamycin, tetracycline, nitrofurantoin, chloramphenicol, 
and trimethoprim–sulfamethoxazole, (9). All isolates were 
further characterized by spa typing, multilocus sequence 
typing, and microarray hybridization by using the Alere 
Identibac S. aureus Genotyping chip (Alere Technologies 
GmbH, Jena, Germany) as described (10–12).
The presence of the mecA homologue was verifi ed 
for all 10 isolates. All PCR amplicons demonstrated 100% 
identity with the DNA sequence of mecALGA251 (National 
Center for Biotechnology Information no. FR821779.1). 
The strains originated from geographically diverse areas (5 
federal states of Germany) and were isolated from different 
infection sites (Table). All strains were identifi ed as MRSA 
by the VITEK 2 system (growth in the presence of 6 μg/
mL cefoxitin according to the VITEK 2 Advanced Expert 
System), although oxacillin MICs were rather low (0.5 μg/
mL) or moderately high (≈4 μg/mL) (Table). Phenotypic 
resistance toward non–β-lactams was not detected.
As has been described for atypical MRSA, 4 strains 
belonged to ST130 and 1 strain belonged to ST1945 
(differs from ST130 by 1 allele) (3–5). The remaining 5 
isolates were assigned to ST599 (differs from ST121 by 2 
alleles) (Table). ST599 has been reported for methicillin-
susceptible isolates from humans in Europe, Asia, and 
Africa (www.mlst.net). The Figure shows a minimum 
spanning tree based on 4,197 entries of the S. aureus 
multilocus sequence type database (http://saureus.mlst.
net/) as of January 19, 2012 (Figure, panel A) and a detailed 
view of the branches and STs harboring strains with the 
novel mecA homologue published (Figure, panel B) (3–5).
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Microarray hybridization data revealed that the agr type 
I and capsule type 5 seem to be associated with ST599 and 
agrIII and that clonal complex (CC) 130 isolates harbor the 
capsule type 8 encoding gene. CC130 and ST599 isolates 
were positive for the surface-associated proteins clfA, 
clfB, fnbA, and bbp. All ST599 strains produced a positive 
hybridization result for 1 of the gene variants encoding 
the toxin responsible for toxic shock syndrome (tst1 or 
tst-bov), and all but 1 of them harbored the enterotoxins 
C (sec) and L (sel), indicating the presence of an S. aureus 
pathogenicity island that encodes superantigens (13). 
Positive or ambiguous hybridization signals for ccrB1, 
ccrA3, and ccrB3 were obtained for 5 isolates, suggesting 
the presence of the SCCmecXI in those strains, according 
to the results of Shore et al. (4).
Conclusions
Our fi ndings of CC130 and ST599 MRSA harboring 
mecALGA251 in several companion animal species suggest 
that in Germany, the presence of the mecA homologue 
in MRSA is not exclusively associated with CC130. This 
fi nding supports the hypothesis that some, if not all, MRSA 
strains that harbor the novel mecA variant can cause 
infections among a broad variety of hosts, as has been shown 
for MRSA of human, equine, canine, and other companion 
animal origins (1,7). All currently known mecALGA251–
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Table. Characteristics of 10 methicillin-resistant Staphylococcus aureus isolates harboring mecALGA251 obtained from companion 
animals, Germany, 2008–2011* 
IMT no. Original no. 
Year 
isolated Host Site Clinical signs 
Free-ranging 





17403 VB 999987 2008 Cat Eye Purulent infection Yes Rhineland-
Palatinate
?4 t10033 1945 
21135 VB 964992 2010 Cat Wound Lymphadenitis Yes Bavaria ?4 t843 130 
21231 VB 971931 2010 Cat Skin Dermatitis Unknown Hessia 1 t1773 130 
24068 VB 961584 2010 Cat Tachea Stridor Yes Hessia 0.5 t10006 599 
25044 VB 969929 2010 Dog Abscess Tumor, dolor No Bavaria 2 t1694 599 




2 t278 599 
25470 VB 972406 2010 Dog Eye Purulent infection No Bavaria 2 t1694 599 
25715 VB 969935 2010 Guinea 
pig
Fistula Purulent infection No Hessia 2 t843 130 
28299 VB 952042 2011 Cat Phlegmon Dermatitis Yes Bavaria 1 t278 599 
28429 IMT 2272/11 2011 Cat Abscess Fever Yes Berlin ?4 t10009 130 
*IMT, Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany; OXA, oxacillin; ST, sequence type; VB, Vet Med Labor GmbH, 
Ludwigsburg, Germany. All isolates were positive for nuc and negative for mecA according to PCR to detect MRSA (8), and all were positive for 
mecALGA251 according to PCR to detect the novel mecA homologue (5).
†Detected by the VITEK 2 system (bioMérieux, Nürtingen, Germany). 
‡Spa repeats and spa type determined according to Harmsen et al. (11) and the Ridom SpaServer (http://spaserver.ridom.de). 
§Determined according to Enright et al. (10).
Figure. Minimum spanning tree based on multilocus sequence typing data from 4,197 Staphylococcus aureus strains (A) and an enlarged 
view of 1 phylogenetic group (B). Each circle represents a distinct sequence type (ST), and circle size is proportional to ST frequency. A 
color version of this fi gure, showing mecALGA251-positive S. aureus strains of companion animal origin reported in this study and sequence 
data from published multilocus sequence typing results (3–5); ST599 methicillin-resistant S. aureus; and ST2024 methicillin-sensitive S. 
aureus isolated from a wild rat, is available online (wwwnc.cdc.gov/EID/article/18/12/12-0238-F1.htm).
MRSA Variant in Companion Animals
carrying MRSA were observed in a distinct section of 
the S. aureus population (Figure, panel B). Whether this 
phylogenetic group possesses the ability to integrate the 
novel mecA variant needs to be further investigated.
In the past, mecALGA251–carrying MRSA could have 
been misidentifi ed as methicillin sensitive by routine PCR. 
However, all isolates were correctly identifi ed as MRSA by 
the VITEK 2 system, as reported (4).
Of the 10 isolates, 7 were found in specimens from cats. 
A recent study identifi ed cats as a potential natural reservoir 
for S. aureus of CC133, a genetic lineage that has also been 
reported for S. aureus of ruminant origin (14). Moreover, 
we have identifi ed a CC130 strain (MSSA_ST2024, t8403) 
from a wild rat (IMT21250; ID4035) (www.mlst.net). In 
addition, CC130 MRSA containing the mecA homologue 
has only recently been reported for isolates from humans 
in Germany (5).
Although many investigators focus on livestock-
associated MRSA, and because particular companion 
animal lineages of MRSA seem to be lacking, transmission 
of MRSA between companion animals and human family 
members in close proximity might be underestimated, 
especially in cases of recurrent infection (15). The 
emergence of MRSA harboring the novel mecA homologue 
has consequences for the verifi cation methods for MRSA 
used in veterinary medicine; implementation of new 
methods will be inevitable. Their supposed restriction 
to only a few genetic lineages and the potential risk for 
interspecies transmission of atypical MRSA between 
companion animals and their owners in household 
environments needs further elucidation.
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